Drugmakers agree on landmark vaccines deal for poor
LONDON (Reuters) – Several drug firms have agreed on a landmark deal to supply up to 200 million doses a year of cut-price pneumococcal vaccines to developing nations, according to the global immunization alliance that is overseeing the deal.
